Hysingla ER (Purdue Pharma LP)
Welcome to the PulseAid listing for the Hysingla ER drug offered from Purdue Pharma LP. This Opioid Agonist [EPC],Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Purdue Pharma LP |
NON-PROPRIETARY NAME: | hydrocodone bitartrate |
SUBSTANCE NAME: | HYDROCODONE BITARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Opioid Agonist [EPC],Opioid Agonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-01-15 |
END MARKETING DATE: | 0000-00-00 |
Hysingla ER HUMAN PRESCRIPTION DRUG Details:
Item Description | Hysingla ER from Purdue Pharma LP |
LABELER NAME: | Purdue Pharma LP |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2015-01-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59011-271_5ae3a057-7eb3-4166-8f76-3cf8d910ca9d |
PRODUCT NDC: | 59011-271 |
APPLICATION NUMBER: | NDA206627 |
Other HYDROCODONE BITARTRATE Pharmaceutical Manufacturers / Labelers: